CONCLUSIONS: The incidence of tonsillar cancer in Sweden is increasing, particularly among men. Risk factors other than smoking may have contributed to the observed secular trend in men. In women, however, smoking can be a part of the explanation. Further studies to look at changes in other environmental factors, such as human papilloma virus (HPV) infection, are clearly warranted. OBJECTIVES: Head and neck cancer is related to smoking habits and smoking has decreased substantially during the last 30 years in Sweden. However, there is suspicion that the incidence of tonsillar cancer has increased in the last 30 years as it has in the USA and Finland, in spite of reduced prevalence of known risk factors. The time trends of oral and oropharygeal cancer have been studied in Sweden, but not tonsillar cancer specifically. SUBJECTS AND METHODS: We used the Swedish Cancer Registry to assess the secular trend of incidence of tonsillar cancer in Sweden since 1960. For comparison we investigated the incidence of other oral cancers and lung cancer, which are also smoking-related. The prevalence of smoking was investigated for reference. Age-standardized incidence rates were calculated and linear regression was used to evaluate secular trends. RESULTS: The incidence of tonsillar cancer increased by 2.6% per year in men and 1.1% in women. No similar increase was seen in the other oral cancers. For lung cancer there was a decrease in the incidence in men, but in women the incidence is still increasing.
CONCLUSIONS: The incidence of tonsillar cancer in Sweden is increasing, particularly among men. Risk factors other than smoking may have contributed to the observed secular trend in men. In women, however, smoking can be a part of the explanation. Further studies to look at changes in other environmental factors, such as human papilloma virus (HPV) infection, are clearly warranted. OBJECTIVES: Head and neck cancer is related to smoking habits and smoking has decreased substantially during the last 30 years in Sweden. However, there is suspicion that the incidence of tonsillar cancer has increased in the last 30 years as it has in the USA and Finland, in spite of reduced prevalence of known risk factors. The time trends of oral and oropharygeal cancer have been studied in Sweden, but not tonsillar cancer specifically. SUBJECTS AND METHODS: We used the Swedish Cancer Registry to assess the secular trend of incidence of tonsillar cancer in Sweden since 1960. For comparison we investigated the incidence of other oral cancers and lung cancer, which are also smoking-related. The prevalence of smoking was investigated for reference. Age-standardized incidence rates were calculated and linear regression was used to evaluate secular trends. RESULTS: The incidence of tonsillar cancer increased by 2.6% per year in men and 1.1% in women. No similar increase was seen in the other oral cancers. For lung cancer there was a decrease in the incidence in men, but in women the incidence is still increasing.
Authors: Andrew P Stein; Sandeep Saha; Jennifer L Kraninger; Adam D Swick; Menggang Yu; Paul F Lambert; Randall J Kimple Journal: Cancer J Date: 2015 May-Jun Impact factor: 3.360
Authors: Kristina R Dahlstrom; Gabriel Calzada; Jennifer D Hanby; Adam S Garden; Bonnie S Glisson; Guojun Li; Dianna B Roberts; Randal S Weber; Erich M Sturgis Journal: Cancer Date: 2012-06-26 Impact factor: 6.860
Authors: Gypsyamber D'Souza; Neil D Gross; Sara I Pai; Robert Haddad; Karen S Anderson; Shirani Rajan; Jennifer Gerber; Maura L Gillison; Marshall R Posner Journal: J Clin Oncol Date: 2014-04-28 Impact factor: 44.544
Authors: David I Conway; Darren R Brenner; Alex D McMahon; Lorna M D Macpherson; Antonio Agudo; Wolfgang Ahrens; Cristina Bosetti; Hermann Brenner; Xavier Castellsague; Chu Chen; Maria Paula Curado; Otávio A Curioni; Luigino Dal Maso; Alexander W Daudt; José F de Gois Filho; Gypsyamber D'Souza; Valeria Edefonti; Eleonora Fabianova; Leticia Fernandez; Silvia Franceschi; Maura Gillison; Richard B Hayes; Claire M Healy; Rolando Herrero; Ivana Holcatova; Vijayvel Jayaprakash; Karl Kelsey; Kristina Kjaerheim; Sergio Koifman; Carlo La Vecchia; Pagona Lagiou; Philip Lazarus; Fabio Levi; Jolanta Lissowska; Daniele Luce; Tatiana V Macfarlane; Dana Mates; Elena Matos; Michael McClean; Ana M Menezes; Gwenn Menvielle; Franco Merletti; Hal Morgenstern; Kirsten Moysich; Heiko Müller; Joshua Muscat; Andrew F Olshan; Mark P Purdue; Heribert Ramroth; Lorenzo Richiardi; Peter Rudnai; Stimson Schantz; Stephen M Schwartz; Oxana Shangina; Lorenzo Simonato; Elaine Smith; Isabelle Stucker; Erich M Sturgis; Neonila Szeszenia-Dabrowska; Renato Talamini; Peter Thomson; Thomas L Vaughan; Qingyi Wei; Deborah M Winn; Victor Wunsch-Filho; Guo-Pei Yu; Zuo-Feng Zhang; Tongzhang Zheng; Ariana Znaor; Paolo Boffetta; Shu-Chun Chuang; Marianoosh Ghodrat; Yuan-Chin Amy Lee; Mia Hashibe; Paul Brennan Journal: Int J Cancer Date: 2014-08-23 Impact factor: 7.396
Authors: David Lindquist; Mircea Romanitan; Lalle Hammarstedt; Anders Näsman; Hanna Dahlstrand; Johan Lindholm; Liselotte Onelöv; Torbjörn Ramqvist; Weimin Ye; Eva Munck-Wikland; Tina Dalianis Journal: Mol Oncol Date: 2007-09-01 Impact factor: 6.603